Apolipoprotein E gene ε2/ε3/ε4 polymorphism and myocardial infarction: Case-control study in a large population sample

International Journal of Cardiology

Volumn 125, Issue 1, 2008, Pages 116-117

  Koch, Werner ^a   Hoppmann, Petra ^a   Schömig, Albert ^a   Kastrati, Adnan ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Apolipoprotein E; Atherosclerosis; Genetics; Myocardial infarction

Indexed keywords

APOLIPOPROTEIN E;

ARTICLE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE FREQUENCY; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; POPULATION GENETICS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; CASE-CONTROL STUDIES; GENOTYPE; HUMANS; MYOCARDIAL INFARCTION; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 39749151040     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.01.012     Document Type: Article

References (5)

1. Song Y., Stampfer M.J., and Liu S. Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease. Ann Intern Med 141 (2004) 137-147
2. Slooter A.J.C., Cruts M., Hofman A., et al. The impact of APOE on myocardial infarction, stroke, and dementia. The Rotterdam Study. Neurology 62 (2004) 1196-1198
3. Koch W., Ehrenhaft A., Griesser K., et al. TaqMan systems for genotyping of disease-related polymorphisms present in the gene encoding apolipoprotein E. Clin Chem Lab Med 40 (2002) 1123-1131
4. Miyata M., and Smith J.D. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and β-amyloid peptides. Nat Genet 14 (1996) 55-61
5. Cullen P., Cignarella A., Brennhausen B., Mohr S., Assmann G., and von Eckardstein A. Phenotype-dependent differences in apolipoprotein E metabolism and in cholesterol homeostasis in human monocyte-derived macrophages. J Clin Invest 101 (1998) 1670-1677